[1] 何燕玲,马弘,张岚, 等. 综合医院就诊者中抑郁焦虑障碍的患病率调查[J]. 中华内科杂志, 2009, 48 (9): 748-751.
[2] 何筱衍,李春波. 焦虑障碍躯体症状的临床研究进展[J]. 中国全科医学,2008,11(5A):774-776.
[3] PURVES K L, COLEMAN J R I, MEIER S M, et al. A major role for common genetic variation in anxiety disorders[J]. Mol Psychiatry, 2020, 25(12): 3292-3303.
[4] HE C J, ZHAI C L, HUANG S D, et al. Anxiety predicts poor prognosis in patients with hypertrophic cardiomyopathy[J]. Front Cardiovasc Med, 2022, 9: e890506.
[5] JÖNSSON P. Respiratory sinus arrhythmia as a function of state anxiety in healthy individuals[J]. Int J Psychophysiol, 2007, 63(1): 48-54.
[6] SUNDEL K L, STAIN-MAHNGREN R, ANDERSSON A, et al. High frequency of anxiety and angina pectoris in depressed women with coronary heart disease[J]. Gend Med, 2007, 4(2): 146-156.
[7] SMITH D F, STERNDORFF B, ROPCKE G, et al. Prevalence and severity of anxiety, depression and type A behaviors in angina pectoris[J]. Scand J Psychol, 1996, 37(3): 249-258.
[8] KNOX S S, GUO X, ZHANG Y, et al. AGT M235T genotype/anxiety interaction and gender in the HyperGEN Study[J]. PLoS One, 2010, 5(10): e13353.
[9] DEMASO D R, CALDERON J, TAYLOR G A,et al. Psychiatric disorders in adolescents with single ventricle congenital heart disease[J]. Pediatrics, 2017, 139(3): e20162241.
[10] LI H, DU Z, ZHANG L, et al. The relationship between angiotensinogen gene polymorphisms and essential hypertension in a northern Han Chinese population [J]. Angiology, 2014, 65(7): 614-619.
[11] LONGSTAFF C, KOLEV K. Basic mechanisms and regulation of fibrinolysis [J]. J Thromb Haemost, 2015, 13 (Suppl 1): S98-S105.
[12] YENILMEZ C, OZDEMIR KOROGLU Z, KURT H, et al. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes [J]. J Clin Pharm Ther, 2017, 42(1): 103-107.
[13] KEVERE L, PURVINA S, BAUZE D, et al. Homocysteine and MTHFR C677T polymorphism in children and adolescents with psychotic and mood disorders [J]. Nord J Psychiatry, 2014, 68(2): 129-136.
[14] LIU P F, DING B, ZHANG J Y, et al. Association between MTHFR C677T polymorphism and congenital heart disease [J]. Int Heart J, 2020, 61(3): 553-561.
[15] ZHANG X, NORTON J, CARRIÈRE I, et al. Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder[J]. Sci Rep, 2017, 7:42676.
[16] WANG Y, LIU W, XIAO Y, et al. Association of apelin and apelin receptor polymorphisms with the risk of comorbid depression and anxiety in coronary heart disease patients[J]. Front Genet, 2020, 11: 893.
[17] MEIER S M, DECKERT J. Genetics of anxiety disorders[J]. Curr Psychiatry Rep, 2019,21(3):16.
[18] ZHU Z, ZHU X, LIU C L, et al. Shared genetics of asthma and mental health disorders: a large-scale genome-wide cross-trait analysis [J]. Eur Respir J, 2019, 54(6):1901507.
[19] AYERBE L, AYIS S A, CRICHTON S, et al. Natural history, predictors and associated outcomes of anxiety up to 10 years after stroke: the South London Stroke Register[J]. Age Ageing, 2014, 43(4): 542-547.
[20] TAROZA S, RASTENYTĖ D, BURKAUSKAS J, et al. Deiodinases, organic anion transporter polypeptide polymorphisms and symptoms of anxiety and depression after ischemic stroke[J]. J Stroke Cerebrovasc Dis, 2020, 29(9): 105040.
[21] MOSER D A, PAOLONI-GIACOBINO A, STENZ L, et al. BDNF methylation and maternal brain activity in a violence-related sample[J]. PLoS One, 2015, 10(12): e0143427.
[22] KANG H J, KIM K O, KIM J W, et al. A longitudinal study of the associations of BDNF genotype and methylation with poststroke anxiety[J]. Int J Geriatr Psychiatry, 2019, 34(11): 1706-1714.
[23] CAMPBELL C, CAVALLERI G L, DELANTY N. Exploring the genetic overlap between psychiatric illness and epilepsy: a review[J]. Epilepsy Behav, 2020, 102:106669.
[24] DOHERTY C, HOGUE O, FLODEN D P, et al. BDNF and COMT, but not APOE, alleles are associated with psychiatric symptoms in refractory epilepsy[J]. Epilepsy Behav, 2019, 94:131-136.
[25] CHRISTENSEN K D, ROBERTS J S, WHITEHOUSE P J, et al. Disclosing pleiotropic effects during genetic risk assessment for Alzheimer disease: a randomized trial[J]. Ann Intern Med, 2016, 164(3): 155-163.
[26] BANNING L C P, RAMAKERS I H G B, DECKERS K, et al. Apolipoprotein E and affective symptoms in mild cognitive impairment and Alzheimer's disease dementia: a systematic review and meta-analysis[J]. Neurosci Biobehav Rev, 2019, 96: 302-315.
[27] GRIGSBY A B, ANDERSON R J, FREEDLAND K E, et al. Prevalence of anxiety in adults with diabetes: a systematic review[J]. J Psychosom Res, 2002, 53(6): 1053-1060.
[28] MAJER-ŃOBODZIŃSKA A, ADAMIEC-MROCZEK J. Glucocorticoid receptor polymorphism in obesity and glucose homeostasis[J]. Adv Clin Exp Med, 2017, 26(1): 143-148.
[29] SOREQ H. Checks and balances on cholinergic signaling in brain and body function[J]. Trends Neurosci, 2015, 38(7): 448-458.
[30] 刘亚凯,司峰,王颂扬,等. 家族聚集性遗尿儿童临床特征及情绪与行为异常的相关因素分析[J]. 临床小儿外科杂志,2023,22(2):112-117.
[31] JØRGENSEN C S, HORSDAL H T, RAJAGOPAL V M, et al. Identification of genetic loci associated with nocturnal enuresis: a genome-wide association study[J]. Lancet Child Adolesc Health, 2021, 5(3): 201-209.
[32] TALATI A, PONNIAH K, STRUG L J, et al. Panic disorder, social anxiety disorder, and a possible medical syndrome previously linked to chromosome 13[J]. Biol Psychiatry, 2008, 63(6): 594-601.
[33] 彭辉,贲亮亮,王健.磷酸二酯酶5基因多态性与阴茎勃起功能障碍的相关性研究[J].临床外科杂志,2022,30(7):677-680.
[34] MARCHAL-ESCALONA C, HERRERA-IMBRODA B, CLEMENTE-POSTIGO M, et al. PDE5A polymorphisms influence on sildenafil treatment success[J]. J Sex Med, 2016, 13(7): 1104-1110.
[35] HAFEZ M H, EL-KAZAZ S E. The impact of phosphodiesterase-5 inhibitor (sildenafil citrate) on some hippocampal neurotransmitters, oxidative stress status, minerals, and anxiety-like behavior in rats[J]. J Adv Vet Anim Res, 2020, 7(2): 281-289.
[36] KOLLER D, PATHAK G A, WENDT F R, et al. Epidemiologic and genetic associations of endometriosis with depression, anxiety, and eating disorders[J]. JAMA Netw Open, 2023, 6(1): e2251214.
[37] 范蕾蕾.子宫内膜异位症的遗传学机制研究进展[J].世界最新医学信息文摘,2019,19(88):38-39, 41.
[38] DRMIC I E, MACKINNON MODI B, MCCONNELL B, et al. Neurodevelopmental functioning in probands and non-proband carriers of 22q11.2 microduplication[J]. Am J Med Genet A, 2022, 188(10): 2999-3008.
[39] 任静然,田执梁.22q11.2缺失综合征精神障碍表现形式的相关性研究[J].中国优生与遗传杂志,2020,28(7):817-819, 862. |
